The Food and Drug Administration expanded its approval of the HPV vaccine to protect more men and women from several types of cancer caused by the human papillomavirus. The vaccine, called Gardasil 9, previously was approved for people 9 through 26 years old. The vaccine is typically given in two doses several months apart for those who are aged 9 through 14, and in three doses for individuals 15 through 26. For those older than 26, the recommended regimen will be three doses. Most sexually active individuals in the United States will become infected by HPV sometime in their lifetimes. In most cases, the virus is cleared by the body's immune system, but when that doesn't occur HPV infections can lead to cervical, anal, vaginal, penile and throat cancers. (edited |
No comments:
Post a Comment